FDA Approved Firdapse® :First  Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)

December 5, 2018 Scipreneur Private Limited 0

FDA Approved Firdapse® :First  Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) By: Catalyst Pharmaceuticals, Inc. NEWS Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has approved Firdapse® [..]